Eli Lilly and Co. (NYSE: LLY) is moving closer to a production start at its massive manufacturing campus in Concord. The pharmaceutical giant has also shattered its investment pledge there and already filled hundreds of jobs.
Lilly is planning to begin medicine production in Concord by the end of this year, a company spokesperson confirmed to the Charlotte Business Journal. The company’s total investment in the site surpassed $2 billion, which is more than double its initial investment pledge of $1 billion.
Lilly also has hired over 400 workers for its Concord operations. It will employ more than 600 people once operations have fully ramped up.
Charlotte Business Journal








